2269/N fundamentals
WUXI BIOLOGICS (CAYMAN) INC financial statements, including revenue, expenses, profit, and loss
The total revenue of 2269/N for the last semiannual is 20.07 B MXN, and it's 4.44% lower compared to the previous semiannual. The net income of H2 23 is 2.66 B MXN.
0.00
Total revenue
Gross profit
Operating income
Pretax income
Net income
Currency: MXN
TTM